Navigation Links
Yale chemist receives NIH Young Investigator Award for antibody targeting
Date:10/23/2007

New Haven, Conn. David Spiegel, assistant professor of organic chemistry at Yale, has received a $1.5 million National Institutes of Health (NIH) Directors New Innovator Award that will support his work designing a rational approach for using antibodies to target a wide variety of cells and disease types.

The New Innovator Awards are reserved for investigators of exceptional promise, who are just beginning their careers and have not yet received a regular research grant from the NIH. New investigators are the future of science, and innovative ideas are its lifeblood, said NIH Director Elias Zerhouni, M.D. The creative scientists we recognize are well-positioned to make significant and potentially transformative discoveries in a variety of areas.

The NIH award will fund Spiegels project titled Small-Molecule Antibody Recruiting Therapeutics for Treating Human Disease, in which he is exploring a novel approach to using antibodies that recognize a single small molecule as a universal agent for targeting and destroying many different pathogens and various types of diseased cells.

For many years, physicians and scientists have used the common small molecule dinitrophenyl (DNP) chloride in immunizations in order to generate anti-DNP antibodies as a test of the status of the immune system. Spiegel is now coupling DNP with agents that recognize pathogens like HIV or surface elements of specific cell types. He theorizes that when cells, bacteria or viruses are exposed to these compounds, they will effectively become coated with DNP, attract the anti-DNP antibodies and then be destroyed.

Scientists have found that for no apparent reason, about 20 percent of people already have DNP antibodies in their system, and it is easy and harmless to induce DNP-antibody production, said Spiegel. Our task will be to rationally design the DNP-compounds that recognize pathogens and act as magnets for the antibody.

Rational design is the key and the advantage to this approach, Spiegel said. Rather than using the brute force approach of screening combinatorial libraries of synthetic compounds, we already have cell-specific and pathogen-specific targeting molecules we can use or modify.

As a synthetic chemist, Spiegel will identify the best pathogen-targeting molecules and the best way of arranging them in relationship to DNP in order to attract DNP-antibodies to the constructed compound. As a physician, his aim is to redirect the immune system to deal as simply as possible with multiple diseases.

The five-year grant to Spiegel, was among the first group of Innovator Awards in the NIH Roadmap for Medical Research Initiative that tests new approaches to supporting research. Awards were made to 30 researchers out of 2200 applicants, of these, only 3 of the awardees, including Spiegel, are in chemistry departments. Yale cell biologist Derek Toomre also received one of the awards for his innovative work on microscopes.

David Spiegel possesses a stunning and eclectic background that has set the stage for an exciting career in academic science, said Gary Brudvig, professor and chair of Chemistry. His training in chemistry and medicine combine to bring great promise to this new area of therapeutics. We are delighted that his creativity and potential as an outstanding investigator has been acknowledged through this NIH award.

Spiegel earned his undergraduate degree with highest honors at Harvard. He matriculated at Yale University in the MD/PhD program, and due to his great interest in chemistry completed the PhD portion of his program pursuing projects in organic synthesis in the laboratory of John Wood. After his postdoctoral training with Stuart L. Schreiber at Harvard, he joined the Yale faculty of in the Department of Chemistry in July 2007.

The NIH Roadmap for Medical Research is a series of far reaching initiatives designed to transform the nations medical research capabilities and the conceptual and technological breakthroughs likely to emerge from these highly innovative approaches to major research challenges are expected to speed progress toward important medical advances.


'/>"/>

Contact: Janet Rettig Emanuel
janet.emanuel@yale.edu
203-432-2157
Yale University
Source:Eurekalert

Related biology news :

1. Chemists create Superbowl molecule; May lead to better health
2. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
3. Duke Chemists Isolating Individual Molecules Of Toxic Protein In Alzheimers, Parkinsons Disease
4. Chemists identify key gene in development of type 1 diabetes
5. Chemists identify immune system mechanism for methamphetamine binges
6. Biochemists report discovery of structure of major piece of telomerase; implications for cancer
7. Red delicious, Northern Spy apples have most antioxidants, chemists find
8. Chemists synthesize molecule that helps body battle cancers, malaria
9. UCR chemist part of team identifying new areas of gene regulation
10. Breakthrough in micro-device fabrication combines biology and synthetic chemistry
11. UCR biochemist goes to Washington with high-protein corn
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/14/2016)... AVIV, Israel , April 14, 2016 ... Behavioral Authentication and Malware Detection, today announced the appointment ... already assumed the new role. Goldwerger,s leadership ... BioCatch, on the heels of the deployment of its ... addition, BioCatch,s behavioral biometric technology, which discerns unique cognitive ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... On Wednesday, June 22, 2016, the ... the Dow Jones Industrial Average edged 0.27% lower to finish ... 0.17%. Stock-Callers.com has initiated coverage on the following equities: Infinity ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ... ). Learn more about these stocks by accessing their free ...
(Date:6/23/2016)... WI (PRWEB) , ... June 23, 2016 , ... ... focused on quality, regulatory and technical consulting, provides a free webinar ... presented on July 13, 2016 at 12pm CT at no charge. , Incomplete ...
(Date:6/23/2016)... , June 22, 2016  Amgen (NASDAQ: ... the QB3@953 life sciences incubator to accelerate ... The shared laboratory space at QB3@953 was created to ... key obstacle for many early stage organizations - access ... the sponsorship, Amgen launched two "Amgen Golden Ticket" awards, ...
(Date:6/22/2016)... 22, 2016 Cell Applications, Inc. and ... to produce up to one billion human induced ... one week. These high-quality, consistent stem cells enable ... and spend more time doing meaningful, relevant research. ... high-volume manufacturing process that produces affordable, reliable HiPSC ...
Breaking Biology Technology: